Garda Capital Partners »

United Therapeutics Corporation shares owned by Garda Capital Partners

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Garda Capital Partners from 13F filings

Historical chart of Garda Capital Partners investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Garda Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Garda Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $548k 2.5k 219.89
2023-09-30 $263k 1.2k 225.87

More positions owned by Garda Capital Partners

Spdr S&p 500 Etf Tr Put Put Option
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Call Call Option
Microsoft Corp Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Call Call Option
Jpmorgan Chase & Co Put Put Option
Amazon Put Put Option
Invesco Qqq Tr Put Put Option
Invesco Qqq Tr Call Call Option
Spdr Dow Jones Indl Average Put Put Option
Spdr Dow Jones Indl Average Call Call Option

View all positions for Garda Capital Partners

Top funds holding United Therapeutics Corporation

Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Dimensional Fund Advisors
AQR Capital Management
Bank of New York Mellon
Norges Bank Investment Management
Palo Alto Investors
OrbiMed Advisors
LSV Asset Management
Charles Schwab Investment Management
Pacer Advisors
Caisse de depot et placement du Quebec
Legal & General Group

View all funds holding United Therapeutics Corporation